Table 4

Effect of weekly vitamin A supplementation on neonatal deaths by cause of death; intention-to-treat analyses, all live births from 1 June 2003 to 30 September 2008

PlaceboVitamin A
All live births (n)31 16431 498
Total neonatal deaths984941
 Infection-specific deaths (n)218224
 Infection-specific deaths/1000 live births7.007.11
 Adjusted OR* (95% CI)1.001.02 (0.84 to 1.23)
 p Value0.86
 Prematurity-specific deaths (n)149132
 Prematurity-specific deaths/1000 live births4.784.19
 Adjusted OR* (95% CI)1.000.88 (0.68 to 1.14)
 p Value0.33
 Asphyxia-specific deaths (n)284284
 Asphyxia-specific deaths/1000 live births9.119.02
 Adjusted OR* (95% CI)1.000.99 (0.83 to 1.19)
 p Value0.95
Other deaths
 Other deaths (n)128117
 Other specific deaths/1000 live births4.113.71
 Adjusted OR* (95% CI)1.000.89 (0.69 to 1.17)
 p Value0.41
 Unexplained deaths (n)175156
 Unexplained deaths/1000 live births5.624.95
 Adjusted OR* (95% CI)1.000.88 (0.71 to 1.10)
 p Value0.26
Cause of death not ascertained
 Unascertained deaths (n)3028
 Unascertained deaths/1000 live births0.960.89
 Adjusted OR* (95% CI)1.000.92 (0.55 to 1.55)
 p Value0.76
  • * Adjusted for clustering by ObaapaVitA cluster of residence.

  • Includes congenital abnormality, accident or injury, malignant tumours and neonatal jaundice.